Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

BVMF/TAKP34 stock hub

BVMF/TAKP34 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BVMF/TAKP34is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

257.5B

Brazil Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BVMF/TAKP34

In the news

Latest news · BVMF/TAKP34

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11.3P50 14.6P75 19.6

Trailing P/E64.9

P25 15.2P50 21.5P75 27.3

ROE1.5

P25 5.3P50 12.3P75 22.5

ROIC2.8

P25 7P50 12.5P75 22.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BVMF/TAKP34 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

216

Groups with data

Currency

JPY

Showing 216 of 216 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Japan
Country code	BR
Employees	47,455
Employees Change	-1,826%
Employees Change Percent	-3.71
Enterprise value	BRL 406.6B
Exchange	Brazil Stock Exchange
Financial currency	JPY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Last refreshed	2026-05-10
Market cap	BRL 257.5B
Price	BRL 81.92
Price currency	BRL
Rev Per Employee	3,305,061.57x
Sector	Healthcare
Sic	2834
Symbol	bvmf/TAKP34
Website	https://www.takeda.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.54%
EV Earnings	102.5x
EV/EBIT	21.65x
EV/EBITDA	9.84x
EV/FCF	11.45x
EV/Sales	2.91x
FCF yield	13.79%
P/B ratio	0.96x
P/E ratio	64.92x
P/S ratio	1.64x
PE Ratio10 Y	54.57x
PE Ratio3 Y	53.83x
PE Ratio5 Y	40.18x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	13.51%
EBITDA Margin	28.53%
FCF margin	22.64%
Gross margin	65.52%
Gross Profit	BRL 102.8B
Gross Profit Growth	-2.28%
Gross Profit Growth Q	8.7%
Gross Profit Growth3 Y	3.03%
Gross Profit Growth5 Y	7.41%
Net Income	BRL 4B
Net Income Growth	-45.73%
Net Income Growth Q	335.66%
Net Income Growth3 Y	-25.63%
Net Income Growth5 Y	-8.97%
Pretax Margin	4.6%
Profit Margin	2.53%
Profit Per Employee	BRL 83,597
ROA	2.47
Roa5y	2.47
ROCE	4.71
ROE	1.5
Roe5y	4.15
ROIC	2.76
Roic5y	4.35

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-2.79%
Cagr3y	2.75%
Div CAGR3	1.99%
EPS Growth	-45.86
EPS Growth Q	330.2
EPS Growth3 Y	-26.17
EPS Growth5 Y	-9.3
FCF Growth	10.2%
FCF Growth Q	-2.08%
FCF Growth3 Y	3.23%
FCF Growth5 Y	8.15%
OCF Growth	6.78%
OCF Growth Q	-2.74%
OCF Growth10 Y	19.3%
OCF Growth3 Y	3.94%
OCF Growth5 Y	8.37%
Revenue Growth	-2.5x
Revenue Growth Q	4.16x
Revenue Growth3 Y	4.21x
Revenue Growth5 Y	6.89x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	BRL 0.29
Assets	BRL 541.3B
Cash	BRL 23B
Current Assets	BRL 97.8B
Current Liabilities	BRL 81.9B
Debt	BRL 190.5B
Debt EBITDA	BRL 4.09
Debt Equity	BRL 0.71
Debt FCF	BRL 5.36
Equity	BRL 268.5B
Interest Coverage	4.62
Liabilities	BRL 272.8B
Long Term Assets	BRL 443.6B
Long Term Liabilities	BRL 190.9B
Net Cash	BRL -167.5B
Net Cash By Market Cap	BRL -65.03
Net Debt EBITDA	BRL 3.74
Net Debt Equity	BRL 0.62
Net Debt FCF	BRL 4.72
Tangible Book Value	BRL -57.1B
Tangible Book Value Per Share	BRL -36.16
WACC	3.41

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.19
Inventory Turnover	1.16
Net Working Capital	BRL 15.3B
Quick ratio	0.54
Working Capital	BRL 17.8B
Working Capital Turnover	BRL 0.27

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.25%
Dividend Growth	-8.82%
Dividend Growth Years	4%
Dividend per share	BRL 2.74
Dividend Years	5
Dividend Yield	3.35%
Ex Div Date	2026-03-30
Last Dividend	BRL 1.38
Payout Frequency	Semi-Annual
Payout Ratio	277.04%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-2.79%
200-day SMA	79.06
3Y total return	8.48%
50-day SMA	82.98
50-day SMA vs 200-day SMA	50over200
All Time High	95.3
All Time High Change	-14.04%
All Time High Date	2026-03-17
All Time Low	66.1
All Time Low Change	23.93%
All Time Low Date	2022-10-19
ATR	1.86
Beta	0.13
Ch YTD	-1.49
High	81.92
High52	95.3
High52 Date	2026-03-17
High52ch	-14.04%
Low	81.92
Low52	70.8
Low52 Date	2025-10-30
Low52ch	15.71%
Ma50ch	-1.28%
Price vs 200-day SMA	3.61%
RSI	40.54
RSI Monthly	51.74
RSI Weekly	49.03
Sharpe ratio	0.79x
Sortino ratio	1.31
Total Return	3.1%
Tr YTD	-0.05
Tr1m	-12.78%
Tr1w	-0.19%
Tr3m	-9.01%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	BRL 21.2B
Operating Income Growth	0.19
Operating Income Growth Q	963.6
Operating Income Growth3 Y	2.45
Operating Income Growth5 Y	20.07
Operating margin	13.51

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,578,176,279%
Net Borrowing	-5,546,129,599.4
Shares Insiders	0.11%
Shares Institutions	47.16%
Shares Qo Q	1.77%
Shares Yo Y	0.25%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	BRL 33B
Average Volume	15.75x
Bv Per Share	170
CAPEX	BRL -6.3B
Ch1m	-14.04
Ch1w	-0.19
Ch1y	-5.68
Ch3m	-10.32
Ch3y	-1.88
Ch6m	14.85
Change	-0.19%
Change From Open	0
Close	82.08
Days Gap	-0.19
Depreciation Amortization	21,039,978,879
Dollar Volume	81.92
Earnings Date	2026-05-13
EBIT	BRL 21.2B
EBITDA	BRL 44.8B
EPS	BRL 2.48
F Score	6
FCF	BRL 35.5B
FCF EV Yield	8.73x
Financing CF	-25,333,118,669
Fiscal Year End	March
Founded	1,781
Goodwill	180,465,977,501.7
Graham Number	49.24707
Graham Upside	-39.88
Income Tax	BRL 3.2B
Investing CF	-11,621,259,043
Is Primary Listing	0
Last Earnings Date	2026-01-29
Last Report Date	2025-12-31
Lynch Fair Value	BRL 6.31
Lynch Upside	-92.3
Ma150	81.81
Ma150ch	0.14%
Ma20	88.49
Ma20ch	-7.42%
Net CF	5,649,293,894
Next Earnings Date	2026-05-13
Open	81.92
P FCF Ratio	7.25
P OCF Ratio	6.17
Ppne	65,369,398,446.2
Price EBITDA	BRL 5.75
Relative Volume	0.06x
Revenue	156,841,696,639x
SBC By Revenue	1.58x
Share Based Comp	2,483,391,796
Tax By Revenue	2.06x
Tax Rate	44.89%
Tr6m	16.53%
Volume	1
Z Score	1.08

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BVMF/TAKP34 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.3%

$2.74 annual per share

Payout ratio

+277.0%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

4 consecutive years of growth

Total shareholder yield

+3.1%

Next ex-dividend date: 2026-03-30

Performance

BVMF/TAKP34 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BVMF/TAKP34?

Insider, institutional, and short-interest positioning.

Institutional ownership

+47.2%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.2%

Negative means the company is buying back shares.

Technical

BVMF/TAKP34 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.5

Neutral momentum band

Price vs 200-day MA

+3.6%

50/200-day relationship not available

Beta (5Y)

0.13

Less volatile than the market

Sharpe ratio

0.79

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BVMF/TAKP34

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvmf/TAKP34 stock rating?

bvmf/TAKP34 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvmf/TAKP34 analysis?

The full report lives at /stocks/bvmf/TAKP34/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvmf/TAKP34?

The latest report frames bvmf/TAKP34 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvmf/TAKP34 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.